Adirna Therapeutics, Inc.

Adirna Therapeutics is a biotechnology company that harnesses the power of artificial intelligence and big data to advance RNA-based precision medicine. Our focus is on the dark genome, the vast and largely unexplored regions of the genome that encode regulatory non-coding RNAs (ncRNAs). We use our proprietary database and AI-powered technology platforms to find and validate novel targets and associated biomarkers effectively and efficiently, and develop precision therapeutics for diseases with high unmet medical needs via an extensive partnership model.